Description: Join us for an insightful session on best practices in setting assumptions and margins for Life and Annuity Products. This session will explore traditional best practices outlined by the ASOPs as well as their application in the context of emerging trends and risks in 2024, such as predictive analytics and AI. The session will also cover evolving trends in assumption governance, as corporate ERM areas become increasingly involved in the assumption setting process. Learning objectives include refreshing and enhancing knowledge of existing ASOPs, as well as understanding strategies for emerging risks that the ASOPs do not yet cover.

Description: The life insurance industry is facing a rapidly changing landscape, with several emerging risks demanding the attention of actuaries and industry professionals. While actuaries commonly examine historical experience to guide our estimates of future outcomes, we are often faced with evidence that some of the forces that dictated past performance no longer persist and in some instances may even turn into contrary forces. This session aims to explore the key challenges and opportunities presented by risks with limited historical context, and discuss strategies to effectively manage them. We will delve into critical emerging risk areas, such as interest rate and asset risk, the rise of AI, climate change, predictive analytics in underwriting, and more. The session will feature speakers who are experts in managing risk, as well as results from interviews with top corporate risk professionals, such as CROs and ERM leads from major insurance and reinsurance companies. Attendees will gain valuable insights into emerging risks and practical strategies to navigate the evolving life insurance landscape.

Description: This session delves into Actuarial Fairness and compares it to other fairness concepts within the context of retirement savings, exploring how these ideas influence behaviors among retirees. We explore how immediate financial pressures and complex financial decisions impact people's willingness and capability to save for retirement. The session will also review traditional retirement solutions and innovative alternatives, assessing how each aligns with fairness principles. Drawing parallels from public discourse on resource distribution in sectors like healthcare, we discuss broader implications of fairness in financial regulations and impacts on policy and decision-making in retirement planning. Learning Outcomes: Attendees will be able to: - Understand the application of fairness concepts, including Actuarial Fairness, to retirement income products. - Explore how perceptions of fairness influence retirement saving behaviors, examining personal finance challenges and the regulatory environment. - Assess innovative retirement solutions' roles in promoting fairness while upholding actuarial integrity. - Analyze the influence of legislation and public policy on the conceptualization, communication, and implementation of fairness in retirement products.

Description: EHRs are a source of digital health data that present both an opportunity and a challenge for insurers. These rapidly maturing data sources contain valuable insights and can create a faster, better applicant experience, but the costs can quickly add up. Listen to panelists discuss various use cases for EHRs, their protective value in relation to traditional underwriting approaches, and other considerations for expanding EHR use. We will take a look at how using EHRs could promote a smart ordering approach allowing us to be quicker and more cost effective, all while understanding the impact to mortality.

Description: Value of new business (VNB) is being used by many companies for various purposes including: internal and external financial reporting, incentive compensation, pricing, capital management, and comparing products, distribution channels or regions on a consistent basis. Presenters will discuss how and why value of new business is used within their companies including: the various methodologies considered, some of the benefits and challenges related to implementing VNB, integrating VNB within their business as usual processes, and managing to VNB.

Description: This session will focus on what is new and coming at the Appointed Actuary (e.g., Actuarial Guideline ((AG)) 53, equity testing, etc.). We will provide highlights from the updated AAT Practice Note. A particular focus will be paid to asset classes that have received regulatory attention recently (e.g., commercial mortgage loans, collateralized loan obligations ((CLOs)), etc.).

Description: Appointed actuaries are facing a number of changes in the regulatory landscape. Some of these occurred in the past few years, such as Actuarial Guideline (AG) 51 (Asset Adequacy Testing for Long-term Care Insurance). Some were very recently put in effect and are evolving, such as AG53 (Modeling and Documentation of Complex Assets). Some are quickly approaching, such as the potential changes to asset adequacy testing requirements for reinsurance ceded by life insurers.

Description: This session will cover the treatment of various forms of reinsurance under Valuation Manual-20 (VM-20). Speakers will discuss the implications of various types of reinsurance agreements on the calculation of principle-based reserves (PBR). This will include coinsurance and modified coinsurance, guaranteed and non-guaranteed yearly renewable term (YRT), as well as financial reinsurance.

Description: Generally accepted accounting practices (GAAP) reporting frameworks are more involved than ever before. From disclosures to assumption changes, to interest rate movements, uncovering the drivers of income emergence can prove hard to do, and even trickier to communicate. This session will revisit how the updated standards create layers of complexity and offer ways to sidestep these obstacles to generate useful earnings analysis by various drivers.

Description: Indexed universal life (IUL) continues to be the most popular universal life (UL) product with sales reaching $1B in Q4 2023, according to LIMRA. There is little long-term experience for IUL and many companies value and model IUL just like UL, but there are material potential differences that need to be considered for valuation and projection purposes.